Human Vascular Endothelial Growth Factor receptor-2 Fc Chimera (VEGFR2 Fc) Enzyme

Proteins and Peptides

Vascular Endothelial Growth Factor receptor-2 Fc Chimera (VEGFR2 Fc)

Insect

Biological Activity: Inhibits the VEGF-dependent proliferation of Human umbilical vein endothelial cells.
Sequence Fragment: 968 AA. The soluble receptor protein contains only the first 7 extracellular domains, which is sufficient for ligand binding.
Tag: Recombinant Human Soluble VEGFR2 is fused with the Fc domain of Human IgG1.

Optimal dilutions/concentrations should be determined by the end user.

Human

145 kDa

Recombinant

> 90% (SDS-PAGE)

Purified by proprietary chromatographic techniques.

2 µg

10 µg

1 mg

Lyophilized

SDS-PAGE

Prior to lyophilization: 1X PBS, pH 7.2.

Shipped within 5-10 working days.

Store dessicated at -20 °C for long-term storage. Upon reconstitution, store at 4°C for up to 7 days and store below -18°C for long-term storage. For long-term storage, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze/thaw cycles.

No

P35968

FLK1,CD309,VEGFR,VEGFR2,VEGFR-2,Protein-tyrosine kinase receptor flk-1,Fetal liver kinase 1,Vascular endothelial growth factor receptor 2

Protein KDR

RUO

THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Reconstitute in sterile water to a concentration of at least 50 µg/ml. This stock solution can be further diluted if required.
Concentration: Prior to lyophilization: 1 mg/ml